Scientific News
The findings of a recent study suggest that L. reuteri eases social difficulties in autistic children.
Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.
The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.
The findings of a recent study suggest that in bacterial vaginosis, certain vaginal microbes disrupt the protective glycans on vaginal epithelial cells, altering processes that mediate cell turnover, death and…
Scientific research, Video
Sponsored by
An open discussion about the future of microbiological analysis through AI integration with Franco Pirovano (Micro srl) and Federico Pirovano (Dynius).
Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex…
The findings of a recent study suggest that different factors, including maternal seeding and phage persistence in the gut, contribute to the colonization of the gut by phages.
The findings of a recent study show that specific gut microbes and their metabolites affect cognition and memory when transplanted into germ-free mice.
Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.
Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.
The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…
Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.
A recent study indicates that the abfA cluster might be used as therapeutic target for constipation in humans.
The findings of a recent study may inform new approaches to treat Crohn’s disease by targeting disease-causing microbes in the gut.
The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.
The findings of a recent study indicate that effective treatments for recurrent UTIs may require the ability to penetrate human tissues.
Alessio Fasano gives an overview of the IHMC Congress to be held in Rome, 22-25 June.
Focusing on restoring microbial cross-feeding interactions emerges as a promising mechanism-informed strategy to reconstruct a healthy gut ecosystem.
The findings of a recent study indicate that antibodies to gut microbes could help identify who may benefit from teplizumab.
The findings of a recent study suggest that the conversion of dietary fiber or lactate to SCFAs influences comorbidity risk associated with HIV.
